retinal vein occlusion
Conditions
Interventions
Experimental group:atorvastatin combined with conbercept
Sponsors
Nanjing Lishui People's hospital
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: ? The patient is aged between 45 and 75 years old, and their visual acuity suddenly decreases within 2 weeks (best corrected visual acuity<0.5). ? According to outpatient dilated pupil fundus fluorescence angiography (FFA), there is delayed venous filling in the early stage of angiography, and fluorescein leakage in the macular area in the late stage of angiography, And the frequency domain optical coherence tomography (SD-OCT) showed a central subfield retinal thickness (CSFT) value greater than 250um, indicating a diagnosis of RVO-ME patients; ? Patients with carotid artery plaques confirmed by carotid artery Doppler ultrasound examination and stenosis<50%.
Exclusion criteria
Exclusion criteria: ? Patients with severe cataracts, macular membrane, optic neuropathy, glaucoma, and uveitis; ? Patients with macular edema secondary to senile macular degeneration and diabetes retinopathy; ? Patients with a history of intravitreal injection, retinal surgery, or laser photocoagulation in the past; ? Patients who have taken lipid-lowering drugs within the past month; ? Patients with severe cardiovascular, cerebrovascular, and liver and kidney dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| best corrected visual acuity;central subfield foveal thickness;injection number;Carotid artery intimal thickness; | — |
Countries
China
Contacts
Public ContactYao Bangtao
Nanjing Lishui People's hospital
Outcome results
None listed